Bionano Genomics (BNGO) Preferred Stock Liabilities (2017)

Bionano Genomics' (BNGO) quarterly Preferred Stock Liabilities came in at $61847.0 in Q4 2017.

Bionano Genomics (BNGO) Preferred Stock Liabilities (2017) Analysis & Trends

Bionano Genomics has disclosed Preferred Stock Liabilities across 1 years of filings, most recently posting $61847.0 for Q4 2017.

Preferred Stock Liabilities for Q4 2017 came in at $61847.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $61847.0 (changed N/A YoY), and the FY2017 annual result was $61847.0, changed N/A from the prior year.
Preferred Stock Liabilities came in at $61847.0 for Q4 2017 at Bionano Genomics.
In the past five years, Preferred Stock Liabilities ranged from a high of $61847.0 in Q4 2017 to a low of $61847.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	-
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Bionano Genomics	14.01 Mn	-366,620.40	3.25 Mn	-

Download Data

Date	Value
Dec 31, 2017	61,847.00